Literature DB >> 30340920

Boiling Histotripsy Ablation of Renal Cell Carcinoma in the Eker Rat Promotes a Systemic Inflammatory Response.

George R Schade1, Yak-Nam Wang2, Samantha D'Andrea3, Joo Ha Hwang3, W Conrad Liles3, Tatiana D Khokhlova4.   

Abstract

Boiling histotripsy (BH) is an experimental focused ultrasound technique that produces non-thermal mechanical ablation. We evaluated the feasibility, short-term histologic effects and the resulting acute inflammatory response to BH ablation of renal cell carcinoma (RCC) in the Eker rat. Genotyped Eker rats were monitored for de novo RCCs with serial ultrasound (US) imaging. When tumors were ≥8 mm, rats underwent ultrasound-guided extracorporeal ablation of the tumor with BH, a pulsed focused US technique that produces non-thermal mechanical ablation of targeted tissues, or a sham US procedure. Treatments targeted approximately 50% of the largest RCC with a margin of normal kidney. BH treated rats were euthanized at 1 (n = 4) or 48 (n = 4) h, and sham patients (n = 4) at 48 h. Circulating plasma cytokine levels were assessed with multiplex assays before and at 0.25, 1, 4, 24 and 48 h following treatment. Kidneys were collected and processed for histologic assessment, immunohistochemistry and intrarenal cytokine concentration measurements. For statistical analysis Student's t-test was used. US-guided BH treatment was successful in all animals, producing hypoechoic regions within the targeted volume consistent with BH treatment effect. Grossly, regions of homogenized tissue were apparent with evidence of focal intra-parenchymal hemorrhage. Histologically, BH produced a sharply demarcated region of homogenized tumor and non-tumor tissue containing acellular debris. BH treatment was associated with significantly increased relative concentration of plasma TNF versus sham treatment (p < 0.05) and transient elevations in high-mobility group box 1 (HMGB1), IL-10 and IL-6 consistent with acute inflammatory response to trauma. Intrarenal cytokine concentrations followed the same trend. At 48 h, enhanced infiltration of CD8+ T cells was observed by immunohistochemistry in both the treated and un-treated contralateral RCC/kidneys in BH-treated animals versus sham treatment. BH treatment was well tolerated with transient gross hematuria and a perinephric hematoma developing in one subject each. The study demonstrates the feasibility of BH ablation of de novo RCC and suggests activation of the acute inflammatory cascade following treatment that appears to stimulate CD8+ T cell infiltration of both treated and untreated tumors. Longer duration chronic studies are ongoing to characterize the longevity and robustness of this response.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Focused ultrasound; High-intensity focused ultrasound; Histotripsy; Immune response; Kidney cancer; Renal carcinoma; T cells

Mesh:

Year:  2018        PMID: 30340920      PMCID: PMC6546431          DOI: 10.1016/j.ultrasmedbio.2018.09.006

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  39 in total

1.  Pulsed cavitational ultrasound therapy for controlled tissue homogenization.

Authors:  Jessica E Parsons; Charles A Cain; Gerald D Abrams; J Brian Fowlkes
Journal:  Ultrasound Med Biol       Date:  2006-01       Impact factor: 2.998

Review 2.  The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity.

Authors:  Michael T Lotze; Herbert J Zeh; Anna Rubartelli; Louis J Sparvero; Andrew A Amoscato; Newell R Washburn; Michael E Devera; Xiaoyan Liang; Mahmut Tör; Timothy Billiar
Journal:  Immunol Rev       Date:  2007-12       Impact factor: 12.988

3.  Intrinsic epithelial cells repair the kidney after injury.

Authors:  Benjamin D Humphreys; M Todd Valerius; Akio Kobayashi; Joshua W Mugford; Savuth Soeung; Jeremy S Duffield; Andrew P McMahon; Joseph V Bonventre
Journal:  Cell Stem Cell       Date:  2008-03-06       Impact factor: 24.633

4.  Activated mammalian target of rapamycin pathway in the pathogenesis of tuberous sclerosis complex renal tumors.

Authors:  Heidi L Kenerson; Lauri D Aicher; Lawrence D True; Raymond S Yeung
Journal:  Cancer Res       Date:  2002-10-15       Impact factor: 12.701

5.  Up-regulation of hypoxia-inducible factor 2alpha in renal cell carcinoma associated with loss of Tsc-2 tumor suppressor gene.

Authors:  Matt Yu Liu; Lorenz Poellinger; Cheryl L Walker
Journal:  Cancer Res       Date:  2003-05-15       Impact factor: 12.701

Review 6.  Use of the spontaneous Tsc2 knockout (Eker) rat model of hereditary renal cell carcinoma for the study of renal carcinogens.

Authors:  Kevin S McDorman; Douglas C Wolf
Journal:  Toxicol Pathol       Date:  2002 Nov-Dec       Impact factor: 1.902

7.  Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy.

Authors:  Lionel Apetoh; François Ghiringhelli; Antoine Tesniere; Michel Obeid; Carla Ortiz; Alfredo Criollo; Grégoire Mignot; M Chiara Maiuri; Evelyn Ullrich; Patrick Saulnier; Huan Yang; Sebastian Amigorena; Bernard Ryffel; Franck J Barrat; Paul Saftig; Francis Levi; Rosette Lidereau; Catherine Nogues; Jean-Paul Mira; Agnès Chompret; Virginie Joulin; Françoise Clavel-Chapelon; Jean Bourhis; Fabrice André; Suzette Delaloge; Thomas Tursz; Guido Kroemer; Laurence Zitvogel
Journal:  Nat Med       Date:  2007-08-19       Impact factor: 53.440

8.  High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes.

Authors:  U Andersson; H Wang; K Palmblad; A C Aveberger; O Bloom; H Erlandsson-Harris; A Janson; R Kokkola; M Zhang; H Yang; K J Tracey
Journal:  J Exp Med       Date:  2000-08-21       Impact factor: 14.307

9.  Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunity.

Authors:  M H M G M den Brok; R P M Sutmuller; S Nierkens; E J Bennink; C Frielink; L W J Toonen; O C Boerman; C G Figdor; T J M Ruers; G J Adema
Journal:  Br J Cancer       Date:  2006-09-05       Impact factor: 7.640

10.  Investigation of HIFU-induced anti-tumor immunity in a murine tumor model.

Authors:  Zhenlin Hu; Xiao Yi Yang; Yunbo Liu; Georgy N Sankin; Eric C Pua; Michael A Morse; H Kim Lyerly; Timothy M Clay; Pei Zhong
Journal:  J Transl Med       Date:  2007-07-11       Impact factor: 5.531

View more
  19 in total

Review 1.  The role of anti-tumor immunity of focused ultrasound for the malignancies: depended on the different ablation categories.

Authors:  Luping Zhang; Chao Yang; Yixing Gao; Jinyun Chen; Wenzhi Chen
Journal:  Int J Clin Oncol       Date:  2022-08-09       Impact factor: 3.850

2.  Histotripsy Ablation of Bone Tumors: Feasibility Study in Excised Canine Osteosarcoma Tumors.

Authors:  Lauren Arnold; Alissa Hendricks-Wenger; Sheryl Coutermarsh-Ott; Jessica Gannon; Alayna N Hay; Nikolaos Dervisis; Shawna Klahn; Irving C Allen; Joanne Tuohy; Eli Vlaisavljevich
Journal:  Ultrasound Med Biol       Date:  2021-08-27       Impact factor: 3.694

Review 3.  The roles of thermal and mechanical stress in focused ultrasound-mediated immunomodulation and immunotherapy for central nervous system tumors.

Authors:  Chulyong Kim; Michael Lim; Graeme F Woodworth; Costas D Arvanitis
Journal:  J Neurooncol       Date:  2022-03-02       Impact factor: 4.506

4.  A Prototype Therapy System for Boiling Histotripsy in Abdominal Targets Based on a 256-Element Spiral Array.

Authors:  Christopher R Bawiec; Tatiana D Khokhlova; Oleg A Sapozhnikov; Pavel B Rosnitskiy; Bryan W Cunitz; Mohamed A Ghanem; Christopher Hunter; Wayne Kreider; George R Schade; Petr V Yuldashev; Vera A Khokhlova
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2021-04-26       Impact factor: 2.725

5.  High-Intensity Focused Ultrasound (HIFU) Triggers Immune Sensitization of Refractory Murine Neuroblastoma to Checkpoint Inhibitor Therapy.

Authors:  Avinash Eranki; Priya Srinivasan; Mario Ries; AeRang Kim; Christopher A Lazarski; Christopher T Rossi; Tatiana D Khokhlova; Emmanuel Wilson; Susan M Knoblach; Karun V Sharma; Bradford J Wood; Chrit Moonen; Anthony D Sandler; Peter C W Kim
Journal:  Clin Cancer Res       Date:  2019-10-15       Impact factor: 13.801

Review 6.  Histotripsy Ablation in Preclinical Animal Models of Cancer and Spontaneous Tumors in Veterinary Patients: A Review.

Authors:  Alissa Hendricks-Wenger; Lauren Arnold; Jessica Gannon; Alex Simon; Neha Singh; Hannah Sheppard; Margaret A Nagai-Singer; Khan Mohammad Imran; Kiho Lee; Sherrie Clark-Deener; Christopher Byron; Michael R Edwards; Martha M Larson; John H Rossmeisl; Sheryl L Coutermarsh-Ott; Kristin Eden; Nikolaos Dervisis; Shawna Klahn; Joanne Tuohy; Irving Coy Allen; Eli Vlaisavljevich
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2021-12-31       Impact factor: 3.267

7.  Boiling Histotripsy-induced Partial Mechanical Ablation Modulates Tumour Microenvironment by Promoting Immunogenic Cell Death of Cancers.

Authors:  Ki Joo Pahk; Cheol-Hee Shin; In Yeong Bae; Yoosoo Yang; Sang-Heon Kim; Kisoo Pahk; Hyungmin Kim; Seung Ja Oh
Journal:  Sci Rep       Date:  2019-06-21       Impact factor: 4.379

Review 8.  Perspectives on Recent Progress in Focused Ultrasound Immunotherapy.

Authors:  Natasha D Sheybani; Richard J Price
Journal:  Theranostics       Date:  2019-10-15       Impact factor: 11.556

Review 9.  Synergies between therapeutic ultrasound, gene therapy and immunotherapy in cancer treatment.

Authors:  Nisi Zhang; James Wang; Josquin Foiret; Zhifei Dai; Katherine W Ferrara
Journal:  Adv Drug Deliv Rev       Date:  2021-07-30       Impact factor: 15.470

10.  Combination of thermally ablative focused ultrasound with gemcitabine controls breast cancer via adaptive immunity.

Authors:  Natasha D Sheybani; Alexandra R Witter; Eric A Thim; Hideo Yagita; Timothy N J Bullock; Richard J Price
Journal:  J Immunother Cancer       Date:  2020-08       Impact factor: 13.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.